Adam Maeder
Stock Analyst at Piper Sandler
(4.68)
# 796
Out of 4,655 analysts
366
Total ratings
56.3%
Success rate
13.6%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Reiterated: Hold | $33 | $24.09 | +36.99% | 7 | Aug 13, 2026 | |
| ISRG Intuitive Surgical | Maintained: Buy | $470 | $390.33 | +20.41% | 51 | Aug 11, 2026 | |
| RMD ResMed | Maintained: Hold | $233 → $225 | $220.37 | +2.10% | 8 | Aug 7, 2026 | |
| GKOS Glaukos | Maintained: Buy | $195 | $185.62 | +5.05% | 18 | Aug 7, 2026 | |
| NYXH Nyxoah | Reiterated: Buy | $7 → $6 | $1.60 | +275.00% | 26 | Aug 6, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $9 | $8.24 | +9.22% | 9 | Aug 6, 2026 | |
| RXST RxSight | Maintained: Hold | $10 | $6.48 | +54.32% | 10 | Aug 6, 2026 | |
| INSP Inspire Medical Systems | Maintained: Hold | $55 → $60 | $57.22 | +4.86% | 50 | Aug 4, 2026 | |
| NSPR InspireMD | Maintained: Buy | $3 | $0.8798 | +240.99% | 8 | Jul 31, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $100 → $101 | $90.81 | +11.22% | 56 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $118 | $110.37 | +6.91% | 19 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $87 | $81.48 | +6.77% | 33 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3.5 | $1.39 | +151.80% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $24.59 | +70.80% | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 → $3 | $3.27 | -8.26% | 13 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.5 → $7 | $0.0484 | n/a | 12 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $50.46 | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.47 → $2.08 | $0.21 | n/a | 2 | Dec 23, 2019 |
STAAR Surgical Company
Aug 13, 2026
Reiterated: Hold
Price Target: $33
Current: $24.09
Upside: +36.99%
Intuitive Surgical
Aug 11, 2026
Maintained: Buy
Price Target: $470
Current: $390.33
Upside: +20.41%
ResMed
Aug 7, 2026
Maintained: Hold
Price Target: $233 → $225
Current: $220.37
Upside: +2.10%
Glaukos
Aug 7, 2026
Maintained: Buy
Price Target: $195
Current: $185.62
Upside: +5.05%
Nyxoah
Aug 6, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $1.60
Upside: +275.00%
Sight Sciences
Aug 6, 2026
Reiterated: Buy
Price Target: $9
Current: $8.24
Upside: +9.22%
RxSight
Aug 6, 2026
Maintained: Hold
Price Target: $10
Current: $6.48
Upside: +54.32%
Inspire Medical Systems
Aug 4, 2026
Maintained: Hold
Price Target: $55 → $60
Current: $57.22
Upside: +4.86%
InspireMD
Jul 31, 2026
Maintained: Buy
Price Target: $3
Current: $0.8798
Upside: +240.99%
Edwards Lifesciences
Jul 24, 2026
Reiterated: Buy
Price Target: $100 → $101
Current: $90.81
Upside: +11.22%
Jul 17, 2026
Reiterated: Buy
Price Target: $115 → $118
Current: $110.37
Upside: +6.91%
Jun 23, 2026
Maintained: Buy
Price Target: $85 → $87
Current: $81.48
Upside: +6.77%
May 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $1.39
Upside: +151.80%
May 5, 2026
Reiterated: Buy
Price Target: $42
Current: $24.59
Upside: +70.80%
Apr 7, 2026
Maintained: Buy
Price Target: $5.5 → $3
Current: $3.27
Upside: -8.26%
Aug 13, 2025
Maintained: Hold
Price Target: $8.5 → $7
Current: $0.0484
Upside: n/a
Apr 9, 2020
Initiated Coverage: Buy
Price Target: $74
Current: $50.46
Upside: n/a
Dec 23, 2019
Reiterated: Buy
Price Target: $3.47 → $2.08
Current: $0.21
Upside: n/a